Meta-analysis by Zeng et al. evaluating the efficacy and safety of anti-PD-1/PD-L1 therapy in glioma patients reported that, while the therapy was generally well tolerated, it did not significantly prolong survival [69]. Here, CD274 is linked to glioma.